Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,008,311 papers from all fields of science
Search
Sign In
Create Free Account
AKT1S1 gene
Known as:
PROLINE-RICH AKT SUBSTRATE, 40-KD
, AKT1S1
, Lobe
Expand
This gene plays a role in the regulation of mTOR signaling.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Signal Transduction
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
T. Vatseba
,
L. Sokolova
,
O. Kovzun
,
V. Pushkarev
,
M. Tronko
Natsional'na Akademiya Nauk Ukrainy. Dopovidi…
2019
Corpus ID: 182481576
2017
2017
Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats
Yunshan Cao
,
Jiyang Song
,
+6 authors
Min Zhang
OncoTarget
2017
Corpus ID: 877386
The molecular mechanism underlying acute right heart failure (RHF) is poorly understood. We used pulmonary artery banding (PAB…
Expand
2016
2016
MYO 6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK 1 / 2 and PRAS 40
Dong Wang
,
Libing Zhu
,
+4 authors
Weizhen Wu
2016
Corpus ID: 62821646
Prostate cancer is the second most frequently diagnosed cancer among males around the world. Myosin VI (MYO6), as a motor protein…
Expand
2013
2013
mTOR/PRAS40 interaction
M. Völkers
,
Mark A Sussman
Cell Cycle
2013
Corpus ID: 22260696
Signals from growth factors, nutrients, energy status, as well as many stressors impinge upon the mechanistic target of rapamycin…
Expand
2013
2013
Abstract A35: Evaluation of MEK inhibitor chemosensitivity in human tumor explants using the Mosaic Blue Assay and relationship to biomarkers by immunohistochemistry.
L. Dauffenbach
,
P. Cash
,
+5 authors
C. Kerfoot
2013
Corpus ID: 86697126
The MEK pathway is activated in most cancers. Several chemotherapeutic agents target this pathway through inhibition of MEK, ERK…
Expand
Review
2012
Review
2012
Role of PRAS 40 in Akt and mTOR signaling in health and disease
Claudia Wiza
,
Emmani B. M. Nascimento
,
D. Ouwens
2012
Corpus ID: 183997
Wiza C, Nascimento EB, Ouwens DM. Role of PRAS40 in Akt and mTOR signaling in health and disease. Am J Physiol Endocrinol Metab…
Expand
Review
2012
Review
2012
The challenges for drug development: cytokines, genes, and stem cells.
K. Maiese
Current Neurovascular Research
2012
Corpus ID: 33685604
Abstract The development of new treatment strategies can offer exciting possibilities for individuals with neurodegenerative…
Expand
2011
2011
Molecular Medicine in Practice PF-04691502 , a Potent and Selective Oral Inhibitor of PI 3 K and mTOR Kinases with Antitumor Activity
Jing Yuan
,
P. Mehta
,
+18 authors
S. Bagrodia
2011
Corpus ID: 19543849
Deregulation of the phosphoinositide 3-kinase (PI3K) signaling pathway such as by PTEN loss or PIK3CA mutation occurs frequently…
Expand
2010
2010
Regulation of mTOR complex 1 in response to growth factors and nutrients
Y. Sancak
2010
Corpus ID: 83072006
In multicellular organisms, cells ensure the simultaneous availability of growth factors and nutrients before they invest in…
Expand
2007
2007
Deregulates Apoptosis in Malignant Melanoma
S. Madhunapantula
,
Arati Sharma
,
G. Robertson
2007
Corpus ID: 41227144
Malignant melanoma is the most invasive and deadly form of skin cancer with no effective therapy to treat advanced disease…
Expand